Keros Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/13/2025 | 5.54 M | $87.75 M | 13.15% | 15.35% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.73 M | $43.20 M | 3.67% | 7.56% |
| VANGUARD GROUP INC | 02/11/2025 | 1.96 M | $30.98 M | 5.42% | 5.42% |
| BRAIDWELL LP | 02/14/2025 | 1.89 M | $29.99 M | 167.86% | 5.25% |
| DARWIN GLOBAL MANAGEMENT, LTD. | 02/14/2025 | 1.69 M | $26.71 M | 10.72% | 4.67% |
| HOLOCENE ADVISORS, LP | 02/14/2025 | 1.20 M | $19.00 M | 42.33% | 3.32% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.10 M | $17.43 M | -41.98% | 3.05% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 1.02 M | $16.13 M | 0.00% | 2.82% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 915,048 | $14.49 M | 139.76% | 2.53% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 909,707 | $14.40 M | -39.93% | 2.52% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 878,159 | $13.90 M | 53.26% | 2.43% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 866,737 | $13.72 M | 0.00% | 2.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 765,436 | $12.12 M | 5.49% | 2.12% |
| MANGROVE PARTNERS | 02/14/2025 | 736,385 | $11.66 M | 156.58% | 2.04% |
| REDMILE GROUP, LLC | 02/14/2025 | 552,506 | $8.75 M | 0.00% | 1.53% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 550,000 | $8.71 M | -37.45% | 1.52% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/14/2025 | 544,001 | $8.61 M | 100.00% | 1.51% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 535,584 | $8.48 M | 50.59% | 1.48% |
| JANE STREET GROUP, LLC | 02/14/2025 | 509,500 | $8.07 M | 100.00% | 1.41% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 450,000 | $7.12 M | 125.00% | 1.25% |
| 02/14/2025 | 407,292 | $6.45 M | 100.00% | 1.13% | |
| WOODLINE PARTNERS LP | 02/14/2025 | 387,701 | $6.14 M | -49.22% | 1.07% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 380,000 | $6.02 M | 0.00% | 1.05% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 328,920 | $5.21 M | 10.50% | 0.91% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 314,541 | $4.98 M | -25.43% | 0.87% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 288,428 | $4.57 M | 0.07% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 279,682 | $4.43 M | 7.52% | 0.77% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 250,000 | $3.96 M | 100.00% | 0.69% |
| 02/14/2025 | 250,000 | $3.96 M | 100.00% | 0.69% | |
| EMERALD ADVISERS, LLC | 02/11/2025 | 244,633 | $3.87 M | 57.27% | 0.68% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 242,633 | $3.84 M | 97.85% | 0.67% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 221,391 | $3.50 M | -31.97% | 0.61% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 216,103 | $3.42 M | 100.00% | 0.60% |
| JPMORGAN CHASE & CO | 02/12/2025 | 213,431 | $3.38 M | 585.90% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 211,309 | $3.35 M | 2,235.42% | 0.59% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 210,000 | $3.32 M | -28.38% | 0.58% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 197,666 | $3.13 M | 100.00% | 0.55% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 190,064 | $3.01 M | 100.00% | 0.53% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 187,500 | $2.97 M | 0.00% | 0.52% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 175,000 | $2.77 M | 153.62% | 0.48% |
| UBS GROUP AG | 02/14/2025 | 174,941 | $2.77 M | 212.91% | 0.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/14/2025 | 155,347 | $2.46 M | 37.95% | 0.43% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 155,163 | $2.46 M | 1.79% | 0.43% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 137,424 | $2.18 M | -13.14% | 0.38% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 130,316 | $2.06 M | 76.69% | 0.36% |
| 02/14/2025 | 130,000 | $2.06 M | 100.00% | 0.36% | |
| TWINBEECH CAPITAL LP | 02/14/2025 | 129,553 | $2.05 M | 742.46% | 0.36% |
| FEDERATED HERMES, INC. | 02/13/2025 | 124,620 | $1.97 M | 100.00% | 0.35% |
| BARCLAYS PLC | 02/13/2025 | 107,542 | $1.70 M | 79.19% | 0.30% |
| PFM HEALTH SCIENCES, LP | 02/14/2025 | 104,323 | $1.65 M | 3.24% | 0.29% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Keros Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 194 institutional investors and hedge funds held shares of Keros Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 5.54 M
BlackRock Funding, Inc. /DE: 2.73 M
VANGUARD GROUP INC: 1.96 M
BRAIDWELL LP: 1.89 M
Darwin Global Management, Ltd.: 1.69 M
Holocene Advisors, LP: 1.2 M
101.79% of Keros Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 37.28 M shares in the last 24 months. This purchase volume represents approximately $583.04 M in transactions.